ORPHAN DRUGS & RARE DISEASES
17-18 October 2018, London, UK
This year’s SMi’s Orphan Drugs and Rare Diseases Conference will bring together regulatory agencies, pharmaceutical companies, non-profit organisations and orphan drugs developers to construct an agenda that addresses the driving economic factors, policies and issues that will affect the development of orphan drugs globally including commercialisation, policies, reimbursement, and pricing.
Keep up to date with the industry and to learn from expert speaker panel, bringing you important new case studies and reports on this year’s relevant topics.
HIGHLIGHTS IN 2018:
View detailed agenda, find out who is speaking and book to attend at http://www.orphandrugs.co.uk/lbtWL
Twitter – @SMIpharm & #smiorphandrugs
LinkedIn – SMi Pharma
Opt-in – SMi Group value your interest in their events and would like to stay in touch – opt-in via https://www.smi-online.co.uk/opt-in to receive SMi’s updates
+44 (0)20 7827 6000
This content is blocked. Accept cookies to view the content.